Simplify Logo

Internship

Summer Intern

In Vitro Pharmacology

Posted on 12/15/2023

ReCode Therapeutics

ReCode Therapeutics

51-200 employees

Develops genetic medicines with advanced delivery technology

Data & Analytics
Hardware
Biotechnology

Compensation Overview

$30 - $35Hourly

Menlo Park, CA, USA

Category
Biology & Biotech
Required Skills
Python
Data Analysis
Requirements
  • Currently enrolled in an undergraduate or master's level graduate degree program in a life sciences discipline with a focus on pharmacology, cell biology, or a related field.
  • Knowledge of IF, IHC, and microscopy.
  • Experience with cell culture and maintenance is a plus.
  • Familiarity with data analysis tools such as Python and GraphPAD.
  • Excellent communication skills, both written and verbal.
  • Demonstrated enthusiasm and curiosity about drug development in the biotech industry.
  • Desire to learn and contribute to impactful projects in the field of in-vitro pharmacology.
Responsibilities
  • Execute experiments involving Immunofluorescence (IF), Immunohistochemistry (IHC), and microscopy techniques.
  • Employ cell culture techniques to support in-vitro studies.
  • Utilize various data analysis tools, including python and GraphPad, to process and interpret experimental results.
  • Collaborate with the broader team to derive meaningful insights from experimental data.
  • Maintain detailed and well-organized laboratory records, including experiment protocols, results, and observations.
  • Prepare and deliver presentations summarizing project progress and findings to the In-Vitro Pharmacology team.
  • Collaborate effectively with team members and cross-functional groups within the organization.
  • Communicate experimental design, results, and interpretations clearly and concisely.
Desired Qualifications
  • Experience with cell culture and maintenance.

ReCode Therapeutics offers a compelling work environment for those passionate about advancing the field of genetic medicine. The company's application of Selective Organ Targeting (SORT) lipid nanoparticle technology allows for precise delivery of genetic therapies beyond traditional liver targets, addressing rare diseases with groundbreaking approaches. Their focus on optimizing mRNA and gene correction further positions them as a forefront player in the biotechnology industry, making it an attractive place for innovative scientists and researchers looking to make a significant impact in medical science.

Company Stage

Series B

Total Funding

$521.8M

Headquarters

Dallas, Texas

Founded

2015

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

8%

2 year growth

71%
INACTIVE